These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
493 related items for PubMed ID: 11249555
1. The pharmacology of donepezil: a new treatment of Alzheimer's disease. Wilkinson DG. Expert Opin Pharmacother; 1999 Nov; 1(1):121-35. PubMed ID: 11249555 [Abstract] [Full Text] [Related]
2. Cholinesterase inhibitors for Alzheimer's disease. Birks J. Cochrane Database Syst Rev; 2006 Jan 25; 2006(1):CD005593. PubMed ID: 16437532 [Abstract] [Full Text] [Related]
3. Donepezil for dementia due to Alzheimer's disease. Birks JS, Harvey R. Cochrane Database Syst Rev; 2003 Jan 25; (3):CD001190. PubMed ID: 12917900 [Abstract] [Full Text] [Related]
4. Donepezil for dementia due to Alzheimer's disease. Birks JS, Harvey RJ. Cochrane Database Syst Rev; 2018 Jun 18; 6(6):CD001190. PubMed ID: 29923184 [Abstract] [Full Text] [Related]
5. Donepezil for dementia due to Alzheimer's disease. Birks J, Harvey RJ. Cochrane Database Syst Rev; 2006 Jan 25; (1):CD001190. PubMed ID: 16437430 [Abstract] [Full Text] [Related]
6. Perspectives in the management of Alzheimer's disease: clinical profile of donepezil. Rogers SL. Dement Geriatr Cogn Disord; 1998 Jan 25; 9 Suppl 3():29-42. PubMed ID: 9853200 [Abstract] [Full Text] [Related]
10. Donepezil for Alzheimer's disease. Benjamin B, Burns A. Expert Rev Neurother; 2007 Oct 25; 7(10):1243-9. PubMed ID: 17939763 [Abstract] [Full Text] [Related]
11. Clinical profile of donepezil in the treatment of Alzheimer's disease. Doody RS. Gerontology; 1999 Oct 25; 45 Suppl 1():23-32. PubMed ID: 9876215 [Abstract] [Full Text] [Related]
12. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Arch Intern Med; 1998 May 11; 158(9):1021-31. PubMed ID: 9588436 [Abstract] [Full Text] [Related]
13. Donepezil for vascular cognitive impairment. Malouf R, Birks J. Cochrane Database Syst Rev; 2004 May 11; (1):CD004395. PubMed ID: 14974068 [Abstract] [Full Text] [Related]
14. Donepezil use in Alzheimer disease. Barner EL, Gray SL. Ann Pharmacother; 1998 Jan 11; 32(1):70-7. PubMed ID: 9475825 [Abstract] [Full Text] [Related]
15. Donepezil for mild and moderate Alzheimer's disease. Birks JS, Melzer D, Beppu H. Cochrane Database Syst Rev; 2000 Jan 11; (4):CD001190. PubMed ID: 11034704 [Abstract] [Full Text] [Related]
17. Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles. Shigeta M, Homma A. CNS Drug Rev; 2001 Jan 11; 7(4):353-68. PubMed ID: 11830754 [Abstract] [Full Text] [Related]
18. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group. Rogers SL, Friedhoff LT. Dementia; 1996 Jan 11; 7(6):293-303. PubMed ID: 8915035 [Abstract] [Full Text] [Related]
19. Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on their efficacy and cost-effectiveness. Wolfson C, Oremus M, Shukla V, Momoli F, Demers L, Perrault A, Moride Y. Clin Ther; 2002 Jun 11; 24(6):862-86; discussion 837. PubMed ID: 12117079 [Abstract] [Full Text] [Related]
20. Donepezil for mild and moderate Alzheimer's disease. Birks J S, Melzer D. Cochrane Database Syst Rev; 2000 Jun 11; (2):CD001190. PubMed ID: 10796620 [Abstract] [Full Text] [Related] Page: [Next] [New Search]